MedTrace Logo

A Study on Probiotic Formula in Autistic Children

NCT06419530 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2024-05-23

No results posted yet for this study

Summary

A Randomized controlled double-blind clinical study on the effectiveness and safety of probiotic formula in Autistic children with gastrointestinal symptoms.

Conditions

Interventions

OTHER

Probiotic formula capsule

The subjects take 4 capsules a day for 84 days.

OTHER

placebo capsule

The subjects take 4 capsules a day for 84 days.

OTHER

FMT capsule

The subjects take 4 capsules a day for 84 days.

Sponsors & Collaborators

  • Third Military Medical University

    lead OTHER

Principal Investigators

  • Yanling Wei, MD · Daping Hospital,Army medical university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-30
Primary Completion
2027-06-30
Completion
2028-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06419530 on ClinicalTrials.gov